{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:54:50Z","timestamp":1789779290817,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":710,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Frailty & Aging"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.14283\/jfa.2022.54","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:47:08Z","timestamp":1663310828000},"page":"420-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Nami Safai","family":"Haeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.14283\/jfa.2022.54_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.12968\/hmed.2018.79.5.253","article-title":"Osteosarcopenia","volume":"79","author":"Paintin","year":"2018","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.14283\/jfa.2022.54_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s001980050129","article-title":"The prevalence of osteoporosis in nursing home residents","volume":"9","author":"Zimmerman","year":"1999","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.14283\/jfa.2022.54_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/gerona\/glw034","article-title":"Incidence of Hip Fracture in U.S. Nursing Homes","volume":"71","author":"Berry","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.14283\/jfa.2022.54_bib4","first-page":"209","article-title":"Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort","volume":"17","author":"Buckinx","year":"2017","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"4","key":"10.14283\/jfa.2022.54_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jamda.2020.07.032","article-title":"Osteosarcopenia Predicts Falls, Fractures, and Mortality in Chilean Community-Dwelling Older Adults","volume":"22","author":"Salech","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.14283\/jfa.2022.54_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"4","key":"10.14283\/jfa.2022.54_bib7","first-page":"601","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Erratum in: Age Ageing"},{"issue":"5","key":"10.14283\/jfa.2022.54_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.14283\/jfa.2022.54_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2018.11.002","article-title":"Use it or lose it to age: A review of bone and muscle communication","volume":"120","author":"Bonewald","year":"2019","journal-title":"Bone"},{"key":"10.14283\/jfa.2022.54_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bone.2015.02.010","article-title":"Bone and muscle: Interactions beyond mechanical","volume":"80","author":"Brotto","year":"2015","journal-title":"Bone"},{"key":"10.14283\/jfa.2022.54_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bone.2017.04.006","article-title":"Molecular bases of the crosstalk between bone and muscle","volume":"115","author":"Karsenty","year":"2018","journal-title":"Bone"},{"issue":"5","key":"10.14283\/jfa.2022.54_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jcb.25040","article-title":"Interactions between muscle tissues and bone metabolism","volume":"116","author":"Kawao","year":"2015","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.14283\/jfa.2022.54_bib13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.14283\/jfa.2022.54_bib14","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","article-title":"Bisphosphonates: mechanisms of action","volume":"97","author":"Rodan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.14283\/jfa.2022.54_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bonr.2018.06.007","article-title":"Bisphosphonate conjugation for bone specific drug targeting","volume":"9","author":"Farrell","year":"2018","journal-title":"Bone Rep"},{"issue":"9","key":"10.14283\/jfa.2022.54_bib16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"18","key":"10.14283\/jfa.2022.54_bib17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.14283\/jfa.2022.54_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamainternmed.2015.0747","article-title":"Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial","volume":"175","author":"Greenspan","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.14283\/jfa.2022.54_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00198-020-05732-2","article-title":"Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study","volume":"32","author":"Zullo","year":"2021","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.14283\/jfa.2022.54_bib20","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2008-2765","article-title":"HORIZON Pivotal Fracture Trial. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.14283\/jfa.2022.54_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2040622310374783","article-title":"Bisphosphonates for the treatment of osteoporosis: insights for clinicians","volume":"1","author":"Lewiecki","year":"2010","journal-title":"Ther Adv Chronic Dis"},{"issue":"7","key":"10.14283\/jfa.2022.54_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/GME.0b013e31827cabca","article-title":"Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women","volume":"20","author":"Park","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"10.14283\/jfa.2022.54_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jbmr.3890","article-title":"Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy","volume":"35","author":"Hain","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.14283\/jfa.2022.54_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jphp.12171","article-title":"Differential impact of the bisphosphonate alendronate on undifferentiated and terminally differentiated human myogenic cells","volume":"66","author":"Shiomi","year":"2014","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"10.14283\/jfa.2022.54_bib25","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.14283\/jfa.2022.54_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S002966511500169X","article-title":"Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity","volume":"74","author":"Wannamethee","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"10.14283\/jfa.2022.54_bib27","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.5888\/pcd17.200167","article-title":"Overweight, Obesity, and Late-Life Sarcopenia Among Men With Cardiovascular Disease, Israel","volume":"17","author":"Lutski","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"10.14283\/jfa.2022.54_bib28","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2147\/DDDT.S328858","article-title":"Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"10.14283\/jfa.2022.54_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/biomedicines5040062","article-title":"Muscle-Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies","volume":"5","author":"Maurel","year":"2017","journal-title":"Biomedicines"},{"key":"10.14283\/jfa.2022.54_bib30","doi-asserted-by":"crossref","first-page":"606947","DOI":"10.3389\/fendo.2020.606947","article-title":"Muscle-Bone Crosstalk in the Masticatory System: From Biomechanical to Molecular Interactions","volume":"11","author":"Buvinic","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.14283\/jfa.2022.54_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.00-0463","article-title":"Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB","volume":"15","author":"Langen","year":"2001","journal-title":"FASEB J"},{"issue":"8","key":"10.14283\/jfa.2022.54_bib32","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest"},{"issue":"10","key":"10.14283\/jfa.2022.54_bib33","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1007\/s10067-021-05757-w","article-title":"Egyptian Academy of Bone Health, Metabolic Bone Diseases. Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?","volume":"40","author":"Miedany","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.14283\/jfa.2022.54_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11845-019-02086-5","article-title":"May zoledronic acid have negative effects on cognition and muscle performance?","volume":"189","author":"Bah\u015fi","year":"2020","journal-title":"Ir J Med Sci"},{"key":"10.14283\/jfa.2022.54_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fendo.2019.00809","article-title":"Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice","volume":"10","author":"Essex","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.14283\/jfa.2022.54_bib36","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jamda.2020.03.017","article-title":"Walking Speed and Muscle Mass Estimated by the D3-Creatine Dilution Method Are Important Components of Sarcopenia Associated With Incident Mobility Disability in Older Men: A Classification and Regression Tree Analysis","volume":"21","author":"Zanker","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.14283\/jfa.2022.54_bib37","doi-asserted-by":"crossref","first-page":"111714","DOI":"10.1016\/j.exger.2022.111714","article-title":"Factor analysis to determine relative contributions of strength, physical performance, body composition and muscle mass to disability and mobility disability outcomes in older men","volume":"161","author":"Zanker","year":"2022","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.14283\/jfa.2022.54_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jcsm.12494","article-title":"Association of change in muscle mass assessed by D3 -creatine dilution with changes in grip strength and walking speed","volume":"11","author":"Duchowny","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["The Journal of Frailty & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134124001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2260134124001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:01:11Z","timestamp":1736463671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2260134124001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2260134124001117"],"URL":"https:\/\/doi.org\/10.14283\/jfa.2022.54","relation":{},"ISSN":["2260-1341"],"issn-type":[{"value":"2260-1341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Frailty & Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jfa.2022.54","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}